Methods of Treating Cancer by Using HEATR1 as a Biomarker.

Technology #2015-311

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
Zhenkun Lou Ph.D.
Tongzheng Liu Ph.D.
Managed By
Leif R. Nelson
Patent Protection
US Patent Pending

Mayo Clinic has discovered that HEATR1 is a novel Akt regulator and a predictor for chemoradioresistance.